Orvig C - Search Results

1

In vitro and in vivo anti-tumor activity of two gold(III) complexes with isoquinoline derivatives as ligands.

Khan TM, Gul NS, Lu X, Wei JH, Liu YC, Sun H, Liang H, Orvig C, Chen ZF. Khan TM, et al. Among authors: orvig c. Eur J Med Chem. 2019 Feb 1;163:333-343. doi: 10.1016/j.ejmech.2018.11.047. Epub 2018 Nov 23. Eur J Med Chem. 2019. PMID: 30529636

2

Potential new inorganic antitumour agents from combining the anticancer traditional Chinese medicine (TCM) liriodenine with metal ions, and DNA binding studies.

Chen ZF, Liu YC, Liu LM, Wang HS, Qin SH, Wang BL, Bian HD, Yang B, Fun HK, Liu HG, Liang H, Orvig C. Chen ZF, et al. Among authors: orvig c. Dalton Trans. 2009 Jan 14;(2):262-72. doi: 10.1039/b813363h. Epub 2008 Nov 19. Dalton Trans. 2009. PMID: 19089006

3

Divalent later transition metal complexes of the traditional chinese medicine (TCM) liriodenine: coordination chemistry, cytotoxicity and DNA binding studies.

Liu YC, Chen ZF, Liu LM, Peng Y, Hong X, Yang B, Liu HG, Liang H, Orvig C. Liu YC, et al. Among authors: orvig c. Dalton Trans. 2009 Dec 28;(48):10813-23. doi: 10.1039/b912553a. Epub 2009 Nov 6. Dalton Trans. 2009. PMID: 20023911

4

Cytotoxicity of the traditional chinese medicine (TCM) plumbagin in its copper chemistry.

Chen ZF, Tan MX, Liu LM, Liu YC, Wang HS, Yang B, Peng Y, Liu HG, Liang H, Orvig C. Chen ZF, et al. Among authors: orvig c. Dalton Trans. 2009 Dec 28;(48):10824-33. doi: 10.1039/b910133k. Epub 2009 Nov 16. Dalton Trans. 2009. PMID: 20023912

5

Long-chain rhenium and technetium glucosamine conjugates.

Bowen ML, Chen ZF, Roos AM, Misri R, Häfeli U, Adam MJ, Orvig C. Bowen ML, et al. Among authors: orvig c. Dalton Trans. 2009 Nov 14;(42):9228-36. doi: 10.1039/b914309b. Epub 2009 Sep 25. Dalton Trans. 2009. PMID: 20449200

6

Structural characteristics of chloroquine-bridged ferrocenophane analogues of ferroquine may obviate malaria drug-resistance mechanisms.

Salas PF, Herrmann C, Cawthray JF, Nimphius C, Kenkel A, Chen J, de Kock C, Smith PJ, Patrick BO, Adam MJ, Orvig C. Salas PF, et al. Among authors: orvig c. J Med Chem. 2013 Feb 28;56(4):1596-613. doi: 10.1021/jm301422h. Epub 2013 Feb 14. J Med Chem. 2013. PMID: 23327489

7

Multi-Target Metal-Based Anticancer Agents.

Chen ZF, Orvig C, Liang H. Chen ZF, et al. Among authors: orvig c. Curr Top Med Chem. 2017 Nov 20;17(28):3131-3145. doi: 10.2174/1568026617666171004155437. Curr Top Med Chem. 2017. PMID: 28982336 Review.

8

Discovery of β-carboline copper(II) complexes as Mcl-1 inhibitor and in vitro and in vivo activity in cancer models.

Lu X, Liu YC, Orvig C, Liang H, Chen ZF. Lu X, et al. Among authors: orvig c. Eur J Med Chem. 2019 Nov 1;181:111567. doi: 10.1016/j.ejmech.2019.111567. Epub 2019 Jul 30. Eur J Med Chem. 2019. PMID: 31401535

9

Recent Advances in Asialoglycoprotein Receptor and Glycyrrhetinic Acid Receptor-Mediated and/or pH-Responsive Hepatocellular Carcinoma- Targeted Drug Delivery.

Li YL, Zhu XM, Liang H, Orvig C, Chen ZF. Li YL, et al. Among authors: orvig c. Curr Med Chem. 2021;28(8):1508-1534. doi: 10.2174/0929867327666200505085756. Curr Med Chem. 2021. PMID: 32368967 Review.

10

Discovery of a Copper-Based Mcl-1 Inhibitor as an Effective Antitumor Agent.

Lu X, Liu YC, Orvig C, Liang H, Chen ZF. Lu X, et al. Among authors: orvig c. J Med Chem. 2020 Sep 10;63(17):9154-9167. doi: 10.1021/acs.jmedchem.9b02047. Epub 2020 Aug 28. J Med Chem. 2020. PMID: 32794745

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

197 results

Search Page